Introduction to GLP-1 Receptors Glucagon-like peptide-1 (GLP-1) is a crucial hormone in the glucagon family, primarily secreted by intestinal L-cells distributed along the gastrointestinal tract
An enzyme called dipeptidyl peptidase-4 (DPP-4) cleaves and inactivates GLP-1 almost instantly, preventing it from reaching therapeutic targets in any meaningful way
The starting dosage is 0.8 milligrams (mg), increased to 2.5 mg after at least 30 days, and then to 5.5 mg after another 30 days
L-carnitine including acetyl L-carnitine , its more bioavailable form has become a star player in the sperm health conversation
Weight loss from GLP-1 therapy can improve insulin resistance and reduce hyperinsulinaemia, which may lower androgen production and increase sex hormone-binding globulin
Semaglutide is part of a class of medications known as GLP-1 receptor agonists